Skip to main content
. 2016 Jan 21;22(3):1160–1171. doi: 10.3748/wjg.v22.i3.1160

Figure 1.

Figure 1

Proportion of genetic abnormalities in gastric cancer. PIK3CA/AKT: Phosphatidylinositol 3-kinase CA/AKT; HER2: Human epidermal growth factor receptor 2; HER3: Human epidermal growth factor receptor 3; FGFR2: Fibroblast growth factor receptor 2; KRAS: Kirsten rat sarcoma oncogene; MET: Mesenchymal-epithelial transition; JAK2: Janus kinase 2; PD-1/PD-L1: Programmed cell death-1/ Programmed cell death-ligand 1.